Phenytoin-induced Stevens–Johnson Syndrome

A BSTRACT Phenytoin is known to cause adverse effects such as gum hypertrophy, coarsening of facies, hirsutism, and hypersensitivity reactions. This case study describes a patient with Moyamoya disease who was treated with phenytoin and subsequently developed Stevens–Johnson syndrome (SJS), a serious skin reaction that has been occasionally reported with Phenytoin. As per the World Health Organization–Uppsala Monitoring Center causality categories, there was a possible relation between the phenytoin treatment and development of SJS in this patient. From this study, it is concluded that patients taking phenytoin should be carefully monitored for the signs of SJS, the medication should be stopped immediately if SJS symptoms appear, and appropriate supportive treatment should be given promptly. Patients who have previously experienced SJS should not be given phenytoin in future. Hence, before prescribing phenytoin, past history of such reaction is needed to be ruled out.

Institutions

Publication Details

Journal
Asian Journal of Pharmaceutical Research and Health Care
Published
2025-10-01
DOI
https://doi.org/10.4103/ajprhc.ajprhc_135_25
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenytoin-induced Stevens–Johnson Syndrome

Asian Journal of Pharmaceutical Research and Health Care
Drug-Induced Adverse Reactions
article

Phenytoin-induced Stevens–Johnson Syndrome

article en

Abstract

A BSTRACT Phenytoin is known to cause adverse effects such as gum hypertrophy, coarsening of facies, hirsutism, and hypersensitivity reactions. This case study describes a patient with Moyamoya disease who was treated with phenytoin and subsequently developed Stevens–Johnson syndrome (SJS), a serious skin reaction that has been occasionally reported with Phenytoin. As per the World Health Organization–Uppsala Monitoring Center causality categories, there was a possible relation between the phenytoin treatment and development of SJS in this patient. From this study, it is concluded that patients taking phenytoin should be carefully monitored for the signs of SJS, the medication should be stopped immediately if SJS symptoms appear, and appropriate supportive treatment should be given promptly. Patients who have previously experienced SJS should not be given phenytoin in future. Hence, before prescribing phenytoin, past history of such reaction is needed to be ruled out.

Asian Journal of Pharmaceutical Research and Health CareVol. 17(4)
Dharmsinh Desai University (IN), KM Shah Dental College and Hospital (IN)
Good health and well-being
Openalex Percentile: Top 33%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.